Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the control of type 2 diabetes. This synthetic peptide mimics the actions of naturally produced GLP-1, a hormone https://companyspage.com/story5817129/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes